• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.



    The Maternal and Child Health Bureau’s FY2019 Accomplishments Include:

    • Maryland Family Planning Program: Conducted 98,042 family planning & reproductive health visits for 66,183 clients of whom 74% are low-income and/or uninsured – served through a network of over 64 clinic sites statewide
    • Clinical Specialty Services: Contributed towards clinical services for 8,353 children and adolescents including visits and genetic counseling in genetic centers, complex care centers, and in pediatric hematology and hemophilia programs
    • Infant Follow Up Services: 6,416 newborns identified in the newborn bloodspot screening program, infant hearing program, sickle cell program, and birth defects program and received follow up services including linkage to care
    • Maryland WIC Program: Each month, nearly 124,000 pregnant, postpartum and breastfeeding women and children up to age five receive nutrition services through a network of 85 sites statewide
    • The MCH Bureau conducted a targeted survey of pediatric providers about Sickle Cell Trait. Most providers indicated familiarity with Sickle Cell Trait, though the extent of knowledge appears limited. Survey results suggested there may be opportunities for provider education on current understanding of health risks related to Sickle Cell Trait, including potential long-term health consequences. Survey results were presented at the 2019 Annual National Convention of the Sickle Cell Disease Association of America.
    • MIECHV SEN Training: The Maternal, Infant, & Early Childhood Home Visiting (MIECHV) program partnered with stakeholders to develop a one-day Substance Exposed Newborns (SEN) training for home visitors, supervisors and community health workers. To inform the training, an expert advisory committee of key stakeholders representing professionals that interact directly with substance-using pregnant women and their children. The training was developed in direct response to the opioid crisis plaguing Maryland and the increased number of SEN identified by DHS.  The training was piloted in 2018, and six regional trainings were held in the first half of 2019, successfully training 288 individuals to date. 

     Updated July 2020